loading
Schlusskurs vom Vortag:
$13.29
Offen:
$13.28
24-Stunden-Volumen:
625.56K
Relative Volume:
0.37
Marktkapitalisierung:
$42.13B
Einnahmen:
$30.27B
Nettoeinkommen (Verlust:
$1.93B
KGV:
29.92
EPS:
0.444
Netto-Cashflow:
$3.45B
1W Leistung:
-2.02%
1M Leistung:
-6.04%
6M Leistung:
+0.73%
1J Leistung:
-5.16%
1-Tages-Spanne:
Value
$13.28
$13.35
1-Wochen-Bereich:
Value
$13.21
$13.68
52-Wochen-Spanne:
Value
$12.57
$15.08

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Name
Firmenname
Takeda Pharmaceutical Co Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
49,281
Name
Twitter
@takedapharma
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
TAK's Discussions on Twitter

Vergleichen Sie TAK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
TAK 13.29 42.13B 30.27B 1.93B 3.45B 0.444
ZTS 175.85 78.47B 9.15B 2.43B 2.31B 4.92
HLN 9.535 42.84B 14.26B 1.55B 0 0.3327
TEVA 17.02 19.19B 16.77B -959.00M 1.37B -2.00
VTRS 13.20 15.67B 15.24B -646.50M 1.88B 1.53

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-03-16 Hochstufung BofA Securities Neutral → Buy
2022-07-19 Hochstufung Cowen Market Perform → Outperform
2021-10-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-04-19 Herabstufung JP Morgan Overweight → Neutral
2019-11-01 Eingeleitet Cowen Market Perform
2019-08-15 Herabstufung Daiwa Securities Outperform → Neutral
Alle ansehen

Takeda Pharmaceutical Co Adr Aktie (TAK) Neueste Nachrichten

pulisher
Nov 20, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 20, 2024
pulisher
Nov 20, 2024

Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform - Quantisnow

Nov 20, 2024
pulisher
Nov 15, 2024

Protein Therapeutics Market Size to be Worth USD 549.4 billion by 2031, at a CAGR of 6.3% | Transparency Market Research, Inc. - GlobeNewswire Inc.

Nov 15, 2024
pulisher
Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Nov 05, 2024

Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading - MSN

Nov 05, 2024
pulisher
Nov 03, 2024

Earnings call: Takeda reports robust H1 growth, revises full-year guidance - Investing.com Australia

Nov 03, 2024
pulisher
Nov 03, 2024

Earnings call: Takeda reports robust H1 growth, revises full-year guidance By Investing.com - Investing.com South Africa

Nov 03, 2024
pulisher
Nov 02, 2024

Torm Plc (NASDAQ: TRMD): Getting A Free Pass? - Stocks Register

Nov 02, 2024
pulisher
Nov 02, 2024

What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register

Nov 02, 2024
pulisher
Oct 21, 2024

Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024
pulisher
Oct 21, 2024

Thailand Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024
pulisher
Oct 16, 2024

Dyne Therapeutics Inc (DYN) gets rating Reiterated from Chardan Capital Markets - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

W & T Offshore Inc (WTI) receives a Buy rating from Stifel - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

JP Morgan Upgrades Mister Car Wash Inc (MCW) to an Overweight from a Neutral - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

BofA Securities upgrades Takeda Pharmaceutical Co ADR (TAK) rating to a Buy - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

What Did We Find About Insider Trading At Ovintiv Inc (NYSE: OVV)? - Stocks Register

Oct 16, 2024
pulisher
Oct 15, 2024

Mizuho analysts downgrades a Neutral rating for Squarespace Inc (SQSP) - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Barclays gives an Equal weight recommendation for Kilroy Realty Corp. (KRC) - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Microchip Technology, Inc. (MCHP) receives a Hold rating from Truist - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Cantor Fitzgerald’s latest rating for EBAY stock - Knox Daily

Oct 15, 2024
pulisher
Oct 11, 2024

Watch this stock’s price performance: Takeda Pharmaceutical Co ADR (NYSE:TAK) - US Post News

Oct 11, 2024
pulisher
Oct 11, 2024

North America Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 11, 2024

Mexico Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 11, 2024

China Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 11, 2024

Italy Retinal Disorder Treatment Market Size & Outlook, 2030 - Grand View Research

Oct 11, 2024
pulisher
Oct 09, 2024

Checking in on Takeda Pharmaceutical Co ADR (TAK) after recent insiders movement - Knox Daily

Oct 09, 2024
pulisher
Oct 08, 2024

AHH stock rated a Buy by Stifel - Knox Daily

Oct 08, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR

Oct 03, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, Pipeline, Medication, Therapies, Treatment Market and Companies by DelveInsight - Barchart

Oct 03, 2024
pulisher
Oct 01, 2024

Ratios in Focus: Analyzing Takeda Pharmaceutical Co ADR (TAK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 01, 2024
pulisher
Sep 26, 2024

Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Brookline Bancorp, Inc. [BRKL] Records 50-Day SMA of $10.01 - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Crescent Energy Co. [CRGY] Records 200-Day SMA of $11.56 - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Tetra Tech, Inc. [TTEK] EVP, CFO makes an insider purchase of 36,830 shares worth 1.72 million. - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

TAK’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

Sep 26, 2024
pulisher
Sep 16, 2024

Vatroslav Mateljic Appointed General Manager of Takeda Canada - Quantisnow

Sep 16, 2024
pulisher
Sep 15, 2024

Ipsen provides update on CONTACT-02 Phase III trial in - GlobeNewswire

Sep 15, 2024
pulisher
Sep 10, 2024

Biotech Soars, And Then Dives, On $5 Billion Opportunity - Investor's Business Daily

Sep 10, 2024
pulisher
Sep 09, 2024

France Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research

Sep 09, 2024

Finanzdaten der Takeda Pharmaceutical Co Adr-Aktie (TAK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic HLN
$9.535
price up icon 0.47%
$17.07
price up icon 1.67%
$13.12
price down icon 0.08%
$122.73
price down icon 0.11%
$58.92
price up icon 0.32%
Kapitalisierung:     |  Volumen (24h):